These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 25188361)

  • 21. Rosacea management: A comprehensive review.
    Sharma A; Kroumpouzos G; Kassir M; Galadari H; Goren A; Grabbe S; Goldust M
    J Cosmet Dermatol; 2022 May; 21(5):1895-1904. PubMed ID: 35104917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea.
    Jackson JM; Fowler J; Moore A; Jarratt M; Jones T; Meadows K; Steinhoff M; Rudisill D; Leoni M;
    J Drugs Dermatol; 2014 Jun; 13(6):699-704. PubMed ID: 24918560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New and Emerging Treatments for Rosacea.
    Gold LM; Draelos ZD
    Am J Clin Dermatol; 2015 Dec; 16(6):457-61. PubMed ID: 26396117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosacea Management: Update on general measures and topical treatment options.
    Schaller M; Schöfer H; Homey B; Hofmann M; Gieler U; Lehmann P; Luger TA; Ruzicka T; Steinhoff M
    J Dtsch Dermatol Ges; 2016 Dec; 14 Suppl 6():17-27. PubMed ID: 27869379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current topical and systemic approaches to treatment of rosacea.
    Korting HC; Schöllmann C
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):876-82. PubMed ID: 19508315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Review of the Current Modalities for the Treatment of Papulopustular Rosacea.
    McGregor SP; Alinia H; Snyder A; Tuchayi SM; Fleischer A; Feldman SR
    Dermatol Clin; 2018 Apr; 36(2):135-150. PubMed ID: 29499797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments.
    van Zuuren EJ; Fedorowicz Z
    Br J Dermatol; 2015 Sep; 173(3):651-62. PubMed ID: 26099423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of the diagnosis and treatment of rosacea.
    Scheinfeld N; Berk T
    Postgrad Med; 2010 Jan; 122(1):139-43. PubMed ID: 20107297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal management of papulopustular rosacea: rationale for combination therapy.
    Bhatia ND; Del Rosso JQ
    J Drugs Dermatol; 2012 Jul; 11(7):838-44. PubMed ID: 22777226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosacea: new and emerging treatments.
    Moustafa FA; Sandoval LF; Feldman SR
    Drugs; 2014 Sep; 74(13):1457-65. PubMed ID: 25154627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging therapies in rosacea.
    Layton A; Thiboutot D
    J Am Acad Dermatol; 2013 Dec; 69(6 Suppl 1):S57-65. PubMed ID: 24229638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.
    Fowler J; Jackson M; Moore A; Jarratt M; Jones T; Meadows K; Steinhoff M; Rudisill D; Leoni M
    J Drugs Dermatol; 2013 Jun; 12(6):650-6. PubMed ID: 23839181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rosacea: An Update in Diagnosis, Classification and Management.
    Kang CN; Shah M; Tan J
    Skin Therapy Lett; 2021 Jul; 26(4):1-8. PubMed ID: 34347259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action.
    Logger JGM; Olydam JI; Driessen RJB
    J Am Acad Dermatol; 2020 Oct; 83(4):1088-1097. PubMed ID: 32360760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel aqueous metronidazole 1% gel with hydrosolubilizing agents (HSA-3).
    Dow G; Basu S
    Cutis; 2006 Apr; 77(4 Suppl):18-26. PubMed ID: 16706246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical overview of azelaic acid.
    Elewski B; Thiboutot D
    Cutis; 2006 Feb; 77(2 Suppl):12-6. PubMed ID: 16566283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosacea: where are we now?
    Bikowski JB; Goldman MP
    J Drugs Dermatol; 2004; 3(3):251-61. PubMed ID: 15176158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S2k guideline: Rosacea.
    Clanner-Engelshofen BM; Bernhard D; Dargatz S; Flaig MJ; Gieler U; Kinberger M; Klövekorn W; Kuna AC; Läuchli S; Lehmann P; Nast A; Pleyer U; Schaller M; Schöfer H; Steinhoff M; Schwennesen T; Werner RN; Zierhut M; Reinholz M
    J Dtsch Dermatol Ges; 2022 Aug; 20(8):1147-1165. PubMed ID: 35929658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical rosacea therapy: the importance of vehicles for efficacy, tolerability and compliance.
    Jackson JM; Pelle M
    J Drugs Dermatol; 2011 Jun; 10(6):627-33. PubMed ID: 21637903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics.
    Conde JF; Yelverton CB; Balkrishnan R; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2007 May; 6(5):495-8. PubMed ID: 17679183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.